Hosted on MSN3mon
Amneal files again for FDA approval of first dihydroergotamine autoinjector
DHE is an established medication used to treat migraines and cluster headaches. It is sold under brand names such as Migranal, Trudhesa, and D.H.E 45, where administration is via nasal spray or ...
pharmaphorum1y
FDA turns down Satsuma’s nasal migraine treatment
The drug – a new dry powder intranasal formulation of the well-established migraine therapy dihydroergotamine mesylate (DHE ... FDA for its Trudhesa nasal spray product in 2021, and Bausch ...